Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction
2012
Obesity and inflammation: the linking mechanism and the complications
2016 Standout
Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: An APEX AMI substudy
2013
Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
2013
Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction
2014
The inflammatory response in myocardial injury, repair, and remodelling
2014 Standout
Inflammatory processes in cardiovascular disease: a route to targeted therapies
2016
Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
2010
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Erratum: Inflammatory processes in cardiovascular disease: a route to targeted therapies
2017
Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
2020 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Works of T. Ueland being referenced
Etanercept or intravenous immunoglobulin attenuates expression of genes involved in post-myocardial infarction remodeling
2005
C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction
2009